Immune checkpoint modulators in cancer immunotherapy: Recent advances and combination rationales
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference80 articles.
1. Enhancement of antitumor immunity by CTLA-4 blockade;Leach;Science,1996
2. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation;Krummel;J. Exp. Med.,1995
3. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones;Harding;Nature,1992
4. Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death;Ishida;EMBO J.,1992
5. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation;Freeman;J. Exp. Med.,2000
Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Versatile hydrogel-based drug delivery platform for multimodal cancer therapy from bench to bedside;Applied Materials Today;2024-08
2. Cyclophosphamide augments the efficacy of in situ vaccination in a mouse melanoma model;Frontiers in Oncology;2023-09-06
3. The effect of gender on the clinical outcome of PD-1/PD-L1 inhibitor in advanced lung cancer patients;Medicine;2023-08-25
4. Does it fit in your pocket? economic burden of PD-1 inhibitors' toxicity in the supplementary health system: evidence from Brazil;BMC Health Services Research;2023-07-21
5. Effect of proton pump inhibitors on the clinical outcomes of PD-1/PD-L1 inhibitor in solid cancer patients;Medicine;2022-09-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3